EUVIMEDEUVIMED entdecken
Open Access

PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway

Changren Zhu, Cuimei Wang, Xiaodong Wang, Shuangshuang Dong, Qing Xu, Jun Zheng

Cytotechnology · 2024-06 · 76 (3) · 351-361

DOI: 10.1007/s10616-024-00626-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytotechnology, online erschienen am 22.04.2024. Verfasst von Changren Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Northern Jiangsu People's Hospital of Jiangsu Province, Yangzhou, 225001 China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is difficult to manage owing to the challenges involved in its treatment and nursing. This study aimed to clarify the roles and mechanisms of action of Poly (A)-binding protein cytoplasmic 1 (PABPC1) on pancreatic cancer. The expression of PABPC1 in pancreatic cancer tissues and cell lines was detected using RT-qPCR and western blotting. The effects of PABPC1 on proliferation, apoptosis, epithelial-mesenchymal transition (EMT), and the PI3K/AKT signaling pathway in pancreatic cancer cells were further investigated using MTT assays, flow cytometry, and western blotting. The expression of PABPC1 was significantly upregulated in pancreatic cancer tissues and cells, whereas PABPC1 downregulation inhibited pancreatic cancer cell proliferation, induced apoptosis, decreased the expression of EMT-associated proteins, and exerted a regulatory effect by inhibiting the PI3K/AKT signaling pathway. In addition, the findings indicated that PABPC1 over-expression significantly promoted pancreatic cancer cell proliferation, inhibited apoptosis, decreased the expression of E-cadherin, enhanced N-cadherin expression, and activating the PI3K/AKT signaling pathway. PABPC1 silencing significantly inhibited proliferation and EMT and induced apoptosis in pancreatic cancer cells. These findings provide novel insights into the role of PABPC1 in the development of pancreatic cancer. Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-024-00626-1.

Schlagwörter

Stichwörter der Autor:innen

EMTPABPC1PI3K/AKT pathwayPancreatic cancerProliferation and apoptosis

Autor:innen und Institutionen

  • Pathology Department, Northern Jiangsu People's Hospital of Jiangsu Province, Yangzhou, 225001 China.
  • Department of Biliary and Pancreatic Surgery, Northern Jiangsu People's Hospital of Jiangsu Province, Yangzhou, 225001 China.
  • Daytime Surgical Ward, Northern Jiangsu People's Hospital of Jiangsu Province, No. 98 Nantong West Road, Yangzhou, 225001 China.

Zitieren

APA

Zhu, C., Wang, C., Wang, X., Dong, S., Xu, Q., & Zheng, J. (2024). PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. Cytotechnology, 76(3), 351-361. https://doi.org/10.1007/s10616-024-00626-1

Vancouver

Zhu C, Wang C, Wang X, Dong S, Xu Q, Zheng J. PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. Cytotechnology. 2024;76(3):351-361. doi:10.1007/s10616-024-00626-1

BibTeX
@article{Zhu2024,
  author = {Zhu, Changren and Wang, Cuimei and Wang, Xiaodong and Dong, Shuangshuang and Xu, Qing and Zheng, Jun},
  title = {PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway},
  journal = {Cytotechnology},
  year = {2024},
  volume = {76},
  number = {3},
  pages = {351--361},
  doi = {10.1007/s10616-024-00626-1}
}
Kostenlos starten →